 Paul Menard-Katcher
Concepts (148)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Eosinophilic Esophagitis | 15 | 2024 | 331 | 2.000 |
Why?
| | Esophageal Stenosis | 2 | 2026 | 60 | 1.070 |
Why?
| | Esophagus | 7 | 2024 | 262 | 1.010 |
Why?
| | Laryngectomy | 1 | 2026 | 17 | 0.940 |
Why?
| | Hernia, Hiatal | 3 | 2022 | 39 | 0.810 |
Why?
| | Esophageal Motility Disorders | 3 | 2020 | 30 | 0.770 |
Why?
| | Eosinophilia | 5 | 2026 | 223 | 0.620 |
Why?
| | Gastritis | 4 | 2026 | 116 | 0.540 |
Why?
| | Gastroenterology | 5 | 2021 | 191 | 0.520 |
Why?
| | Esophagogastric Junction | 2 | 2023 | 55 | 0.510 |
Why?
| | Myotomy | 2 | 2023 | 15 | 0.390 |
Why?
| | Postoperative Complications | 1 | 2026 | 2970 | 0.380 |
Why?
| | Patient Reported Outcome Measures | 3 | 2024 | 497 | 0.380 |
Why?
| | Esophagitis, Peptic | 2 | 2023 | 16 | 0.370 |
Why?
| | Eosinophils | 5 | 2026 | 316 | 0.370 |
Why?
| | Laryngopharyngeal Reflux | 2 | 2021 | 14 | 0.340 |
Why?
| | Colonoscopy | 3 | 2024 | 263 | 0.330 |
Why?
| | Enteritis | 3 | 2022 | 104 | 0.320 |
Why?
| | Manometry | 3 | 2020 | 98 | 0.310 |
Why?
| | Endoscopy, Digestive System | 3 | 2020 | 142 | 0.270 |
Why?
| | Clinical Competence | 6 | 2024 | 1243 | 0.250 |
Why?
| | Deglutition Disorders | 2 | 2022 | 154 | 0.240 |
Why?
| | Laryngeal Neoplasms | 1 | 2026 | 36 | 0.230 |
Why?
| | Quality of Life | 5 | 2024 | 3204 | 0.230 |
Why?
| | Zenker Diverticulum | 1 | 2023 | 12 | 0.200 |
Why?
| | Diagnosis, Computer-Assisted | 1 | 2024 | 92 | 0.200 |
Why?
| | Natural Orifice Endoscopic Surgery | 1 | 2023 | 35 | 0.190 |
Why?
| | Esophageal Achalasia | 1 | 2023 | 29 | 0.190 |
Why?
| | Colonic Polyps | 1 | 2024 | 87 | 0.190 |
Why?
| | Severity of Illness Index | 3 | 2024 | 2930 | 0.190 |
Why?
| | Learning Curve | 2 | 2020 | 71 | 0.180 |
Why?
| | Hyperplasia | 2 | 2020 | 177 | 0.180 |
Why?
| | Balloon Occlusion | 1 | 2022 | 39 | 0.180 |
Why?
| | Tetraspanins | 1 | 2021 | 18 | 0.180 |
Why?
| | Adult | 19 | 2026 | 40777 | 0.170 |
Why?
| | Humans | 33 | 2026 | 145474 | 0.170 |
Why?
| | Prospective Studies | 9 | 2024 | 8057 | 0.170 |
Why?
| | Child | 14 | 2026 | 22707 | 0.160 |
Why?
| | Interleukin-13 | 1 | 2021 | 146 | 0.160 |
Why?
| | Male | 23 | 2026 | 72842 | 0.160 |
Why?
| | Simulation Training | 1 | 2022 | 135 | 0.160 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2026 | 992 | 0.150 |
Why?
| | Female | 22 | 2026 | 78844 | 0.150 |
Why?
| | Sensitivity and Specificity | 1 | 2024 | 1997 | 0.150 |
Why?
| | Artificial Intelligence | 1 | 2024 | 381 | 0.150 |
Why?
| | Middle Aged | 14 | 2026 | 36215 | 0.150 |
Why?
| | Cytokines | 2 | 2020 | 2067 | 0.150 |
Why?
| | Fellowships and Scholarships | 3 | 2021 | 354 | 0.140 |
Why?
| | Competency-Based Education | 2 | 2020 | 81 | 0.140 |
Why?
| | Self Report | 2 | 2024 | 870 | 0.140 |
Why?
| | Barrett Esophagus | 1 | 2020 | 169 | 0.130 |
Why?
| | Proton Pump Inhibitors | 2 | 2021 | 109 | 0.130 |
Why?
| | Adolescent | 10 | 2026 | 22529 | 0.130 |
Why?
| | Child, Preschool | 7 | 2024 | 11853 | 0.120 |
Why?
| | Colon | 1 | 2019 | 309 | 0.120 |
Why?
| | Esophagoscopy | 3 | 2024 | 223 | 0.120 |
Why?
| | Parents | 3 | 2024 | 1403 | 0.120 |
Why?
| | Colitis | 1 | 2019 | 280 | 0.120 |
Why?
| | Fibroblasts | 1 | 2021 | 1025 | 0.120 |
Why?
| | Transition to Adult Care | 1 | 2017 | 103 | 0.110 |
Why?
| | Young Adult | 7 | 2026 | 14218 | 0.110 |
Why?
| | Endothelial Cells | 1 | 2021 | 874 | 0.110 |
Why?
| | Microbiota | 1 | 2022 | 730 | 0.110 |
Why?
| | Education, Medical, Graduate | 2 | 2022 | 562 | 0.110 |
Why?
| | Aged | 8 | 2026 | 26153 | 0.110 |
Why?
| | Risk Factors | 2 | 2026 | 10885 | 0.100 |
Why?
| | Basophils | 1 | 2013 | 52 | 0.100 |
Why?
| | Curriculum | 2 | 2022 | 1070 | 0.090 |
Why?
| | Leukocyte Count | 2 | 2024 | 316 | 0.080 |
Why?
| | Internship and Residency | 1 | 2021 | 1267 | 0.080 |
Why?
| | Endoscopy, Gastrointestinal | 2 | 2022 | 237 | 0.070 |
Why?
| | Surveys and Questionnaires | 3 | 2024 | 6066 | 0.070 |
Why?
| | Cross-Sectional Studies | 3 | 2018 | 5904 | 0.070 |
Why?
| | Treatment Outcome | 4 | 2026 | 11772 | 0.070 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2017 | 1419 | 0.070 |
Why?
| | Glucocorticoids | 1 | 2012 | 531 | 0.070 |
Why?
| | Case-Control Studies | 1 | 2016 | 3623 | 0.070 |
Why?
| | Accreditation | 2 | 2020 | 101 | 0.060 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2006 | 72 | 0.060 |
Why?
| | Injections, Subcutaneous | 1 | 2026 | 170 | 0.060 |
Why?
| | Age Factors | 1 | 2012 | 3342 | 0.050 |
Why?
| | Gene Expression Regulation | 2 | 2021 | 2597 | 0.050 |
Why?
| | Esophageal Mucosa | 1 | 2024 | 22 | 0.050 |
Why?
| | Colitis, Ulcerative | 1 | 2006 | 148 | 0.050 |
Why?
| | Esophageal Sphincter, Lower | 1 | 2023 | 14 | 0.050 |
Why?
| | Program Evaluation | 2 | 2020 | 943 | 0.050 |
Why?
| | Fluticasone | 1 | 2023 | 53 | 0.050 |
Why?
| | Fundoplication | 1 | 2022 | 52 | 0.040 |
Why?
| | Adenoma | 1 | 2024 | 218 | 0.040 |
Why?
| | Stomach | 1 | 2022 | 111 | 0.040 |
Why?
| | Proton Pumps | 1 | 2021 | 8 | 0.040 |
Why?
| | Esophageal Sphincter, Upper | 1 | 2021 | 8 | 0.040 |
Why?
| | Herniorrhaphy | 1 | 2022 | 76 | 0.040 |
Why?
| | Pepsin A | 1 | 2021 | 18 | 0.040 |
Why?
| | Heartburn | 1 | 2021 | 12 | 0.040 |
Why?
| | Time Factors | 1 | 2012 | 7123 | 0.040 |
Why?
| | Phenotype | 2 | 2021 | 3155 | 0.040 |
Why?
| | Printing, Three-Dimensional | 1 | 2022 | 101 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2026 | 2062 | 0.040 |
Why?
| | Dilatation | 1 | 2021 | 71 | 0.040 |
Why?
| | Gene Silencing | 1 | 2021 | 202 | 0.040 |
Why?
| | International Cooperation | 1 | 2021 | 197 | 0.040 |
Why?
| | Aftercare | 1 | 2022 | 222 | 0.040 |
Why?
| | United Arab Emirates | 1 | 2020 | 6 | 0.040 |
Why?
| | Cough | 1 | 2021 | 124 | 0.040 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2006 | 1443 | 0.040 |
Why?
| | RNA, Small Interfering | 1 | 2021 | 637 | 0.040 |
Why?
| | Cohort Studies | 2 | 2020 | 6013 | 0.040 |
Why?
| | Feedback | 1 | 2019 | 180 | 0.040 |
Why?
| | Precancerous Conditions | 1 | 2020 | 166 | 0.030 |
Why?
| | International Classification of Diseases | 1 | 2019 | 150 | 0.030 |
Why?
| | Diagnostic Errors | 1 | 2019 | 178 | 0.030 |
Why?
| | United States | 3 | 2023 | 16098 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2024 | 2953 | 0.030 |
Why?
| | Colorectal Neoplasms | 1 | 2024 | 866 | 0.030 |
Why?
| | Health Care Surveys | 1 | 2017 | 536 | 0.030 |
Why?
| | Patient Discharge | 1 | 2022 | 992 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2020 | 1111 | 0.030 |
Why?
| | Gene Expression | 1 | 2020 | 1476 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2019 | 1508 | 0.030 |
Why?
| | Biopsy | 1 | 2018 | 1082 | 0.030 |
Why?
| | Self Care | 1 | 2017 | 390 | 0.030 |
Why?
| | Benchmarking | 1 | 2015 | 191 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2023 | 5423 | 0.020 |
Why?
| | Neutralization Tests | 1 | 2013 | 76 | 0.020 |
Why?
| | Pandemics | 1 | 2021 | 1707 | 0.020 |
Why?
| | Machine Learning | 1 | 2018 | 587 | 0.020 |
Why?
| | Data Collection | 1 | 2015 | 640 | 0.020 |
Why?
| | Disease Progression | 1 | 2020 | 2864 | 0.020 |
Why?
| | Immunoglobulin E | 1 | 2013 | 315 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2018 | 1767 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2020 | 17291 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2013 | 1261 | 0.020 |
Why?
| | Risk Assessment | 1 | 2020 | 3747 | 0.020 |
Why?
| | Animals | 2 | 2023 | 38030 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 2013 | 1505 | 0.010 |
Why?
| | Ki-67 Antigen | 1 | 2006 | 117 | 0.010 |
Why?
| | Epithelium | 1 | 2006 | 310 | 0.010 |
Why?
| | Microscopy, Fluorescence | 1 | 2006 | 408 | 0.010 |
Why?
| | Regeneration | 1 | 2006 | 197 | 0.010 |
Why?
| | DNA Damage | 1 | 2006 | 437 | 0.010 |
Why?
| | Kinetics | 1 | 2006 | 1567 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2013 | 4560 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2013 | 5983 | 0.010 |
Why?
| | Intestinal Mucosa | 1 | 2006 | 675 | 0.010 |
Why?
| | Epithelial Cells | 1 | 2006 | 1131 | 0.010 |
Why?
| | Mice | 1 | 2013 | 18329 | 0.010 |
Why?
| | Inflammation | 1 | 2006 | 2878 | 0.010 |
Why?
|
|
Menard-Katcher's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|